Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × relatlimab × Clear all

Sponsor

Conditions

Melanoma 4 Advanced Cancer 3 Uveal Melanoma 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Various Advanced Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Microsatellite Unstable Colorectal Cancer 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Liver Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 National Cancer Institute (U.S.) 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Fatty Acids, Omega-3 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Atorvastatin 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡